Summary
The inherited lysosomal storage diseases are a distinct group of inborn errors of metabolism characterised by deficiencies in specific lysosomal enzymes. As many as 40 such disorders have now been described in man. We have measured the activities of up to 16 lysosomal acid hydrolases in plasma and/or extracts of leucocytes and cultured skin fibroblasts from 198 patients referred from throughout Ireland. These 16 assays allowed the biochemical diagnosis of 20 lysosomal storage diseases. Activities were compared with reference ranges to determine homozygotes and heterozygotes. Of the 44 patients with positive results, 15 were diagnosed as being homozygous for a specific lysosomal enzyme deficiency, 4 were identified as having multiple enzyme deficiencies (mucolipidosis Type II/I-cell disease) and 25 had heterozygote (carrier) enzyme levels. Of the latter, 24 were either parents (obligate heterozygotes) or siblings of homozygotes and one was a heterozygote for the X-linked recessively inherited Fabry’s disease.
Similar content being viewed by others
References
Tay, W. Symmetrical changes in the region of the yellow spot in each eye of an infant Trans. Opthalmol, Soc. U.K. 1881: 1, 55–57.
Sachs, B. On arrested cerebral development, with special reference to cortical pathology. J. Nerv. Ment Dis. 1887, 14, 541–554.
Hers, H. G. Inborn lysosomal diseases. Gastroenterology 1965: 48, 625–633.
Hers, H. G. α-Glucosidase deficiency in generalized glycogen storage disease (Pompe’s disease). Biochem. J. 1963: 86, 1–6.
de Duve, C., Wattiaux, R. Functions of lysosomes. Annu. Rev. Physiol, 1966: 28, 435–492.
Callahan, J. W., Lowden, J. A. (eds), Lysosomes and lysosomal storage diseases. New York: Raven Press. 1981: 1–434.
Nelson, J. The mucopolysaccharidoses in Northern Ireland: a clinical, genetic and biochemical study. The Queen’s University of Belfast, M.D., 1985–86.
Hsia, D., Yi-Y. Study of hereditary metabolic diseases using in vitro techniques. Metabolism 1970: 19,309–339.
Galjaard, H. Genetic metabolic diseases. Amsterdam: Elsevier/North-Holland Biomedical Press, 1980.
Kolodny, E. H., Mumford, R. A. Human leucocyte acid hydrolases: characteristics of eleven lysosomal enzymes and study of reaction conditions for their automated analysis. Clin. Chim. Acta 1976: 70, 247–257.
Buchwald, M. Use of cultured human cells for biochemical analysis. Clin. Biochem. 1984: 17, 143–150.
Chen, T. R. In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp. Cell Res. 1977: 104, 255–262,
Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. Protein measurement with the Folin phenol reagent J. Biol. Chem. 1951: 193, 265–275.
Galjaard, H., Mekes, M., De Josselin de Jong, J. E., Niermeijer, M. F. A method for rapid diagnosis of Glycogenosis II. Clin. Chim. Acta 1973: 49. 361–375.
Weissman, B. Synthetic substrates for α-Liduronidase. Methods in Enzymol. 1978: 50, 141–150.
Marsh, J., Fensom, A. H. 4- Methylumbelliferyl α-N-acetylglucosaminidase activity for diagnosis of Sanfillippo B disease. Clin. Genet. 1985: 27, 258–262.
Van Diggelen, O. P., Galjaard, H., Sinnott, M. L., Smith, P. J. Specific activation of lysosomal glycosidase in living fibroblasts by the corresponding glycosylmethyl-p-nitrophenyl triazenes. Biochem. J. 1980: 188, 337–343.
Fluharty, A. L., Stevens, R. L., Sanders, D. L., Kihara, H. Arylsulfatase B deficiency in Maroteaux-Lamy syndrome cultured fibroblasts. Biochem. Biophys. Res. Commun. 1974: 59, 455–461,
Glaser, J. H., Sly, W. S. β-Glucuronidase deficiency mucopolysaccharidosis: methods for enzymatic diagnosis. J. Lab. Clin. Med. 1973: 82, 969–977.
Besley, G. T. N., Moss, S. E. Studies on pyrophosphate diesterase activity in cultured human fibroblasts: a deficiency in Niemann-Pick disease. Clin. Chim. Acta 1981: 117, 75–84.
Wenger, D. A., Clark, C., Saltier, M., Wharton, C. Synthetic substrate β-glucosidase activity in leucocytes: a reproducible method for the identification of patients and carriers of Gaucher’s disease. Clin. Genet. 1978: 13, 145–153.
Daniels, L. B., Glew, R. H. β-Glucosidase assays in the diagnosis of Gaucher’s disease. Clin. Chem. 1982: 28, 569–577.
Humbels, R. Rapid method for measuring arylsulfatases A and B in leucocytes as a diagnosis for sulfatidosis, mucosulfatidosis and mucopolysaccharidosis VI. Clin. Chim. Acta 1976: 68, 339–341.
Baum, H., Dodgson, K. S., Spencer, B. The assay of arylsulfatases A and B in human urine. Clin. Chim. Acta. 1959: 4, 453–455.
Besley, G. T. N., Broadhead, D. M., Young, J. A. Gm2-gangliosidosis variant with altered substrate specificity: evidence for α-locus genetic compound. J. Inherited Metab. Dis. 1987: 10, 403–404.
Grebner, E. E., Wenger, D. A. Use of 4- methylumbelliferyl-6-sulpho-2-acetamido- 2-deoxy-β-D-glucopyranoside for prenatal diagnosis of Tay-Sachs disease using chorionic villus. Prenat. Diagn. 1987: 7, 419–423.
O’Brien, J. S., Okada, S., Fillerup, D. L. et al. Tay-Sachs disease: prenatal diagnosis. Science 1971: 172, 61–64.
Kistler, J. P., Lott, J. T., Kolodny, E, H. et al. Mannosidosis. Arch. Neurol. 1977: 34, 45–51.
Robinson, D., Thorpe, R. Fluorescent assay of α-L-fucosidase. Clin. Chim. Acta 1974: 55, 65–69.
Desnick, R. J., Allen, K. Y., Desnick, S. J., Raman, M. K., Bemlohr, R. W., Krivit, W. Fabry’s disease: enzymatic diagnosis of hemizygotes and heterozygotes. α-Galactosidase activities in plasma, serum, urine and leucocytes. J. Lab. Clin. Med. 1973: 81,157–171.
Desnick, R. J., Bernstein, H. S., Astrin, K. H., Bishop, D. F. Fabry’s disease: molecular diagnosis of hemizygotes and heterozygotes. Enzyme 1987: 38, 54–64.
Reitman, A. L., Varki, A., Komfeld, S. Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5’-diphosphate-N-acetylglucosamine: glycoprotein N-acetyl-glucosam- inylphosphotransferase activity. J. Clin. Invest. 1981: 67, 1574–1579.
Lemansky, P., Gieselmann, V., Hasilik, A., von Figura, K. Synthesis and transport of lysosomal acid phosphatase in normal and I-cell fibroblasts J. Biol. Chem. 1985, 260, 9023–9030.
Waheed, A., Pohlmann, R., Hasilik, A., von Figura, K., van Elsen, A., Leroy, J. G. Deficiency of UDP-N-acetylglucosamine-I-phosphotransferase in organs of I-cell patients. Biochem. Biophys. Res. Commun. 1982: 105, 1052–1058.
Aerts, J. M. F. G., Brul, S., Donker-Koopman, W. E. et al. Efficient routing of glucocerebrosidase to lysosomes requires complex oligosaccharide chain formation. Biochem. Biophys. Res. Commun, 1986: 141, 452–458.
Krivit, W., Paul, N. W. (eds). Bone marrow transplantation for treatment of lysosomal storage diseases. Birth Defects: Original Article Series. New York: Alan R. Liss, Inc. 1986: Vol, 22.
Krivit, W., Lipton, M. E., Lockman, L. A. et al. Prevention of deterioration in Metachromatic Leucody strophy by bone marrow transplantation. Am. J. Med. Sci. 1987: 294, 80–85.
Hobbs, J. R. Displacement bone marrow transplantation and immunoprophylaxis for genetic diseases. Adv. Intern. Med. 1988: 33, 81–118.
Pollard, A. C., Carey, W. F., Nelson, P. V., Poulos, A., Hill, G. N. Enzymological diagnosis of a group of lysosomal storage diseases: review of 5-year experience of 1600 patient-sample referrals. Med. J. Aust 1980: 2, 549–553.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wallace, I.J.C., McCusker, C.A. & McCormick, D. The biochemical diagnosis of lysosomal storage diseases — A review of five years experience. I.J.M.S. 159, 203–209 (1990). https://doi.org/10.1007/BF02937266
Issue Date:
DOI: https://doi.org/10.1007/BF02937266